Home NDC 27854-103-07 Flanax Pain Reliever
Product NDC 27854-103
Requested package NDC 27854-103-07
11-digit product format 278540103
Labeler code 27854
Product ID 27854-103_ec7c8e96-24c5-3652-e053-2995a90a196d
Type HUMAN OTC DRUG
Nonproprietary name Naproxen Sodium
Dosage form TABLET
Route ORAL
Labeler Belmora LLC
Application ANDA079096
Marketing category ANDA
Marketing start 2008-12-16
Marketing end 2023-03-31
Substance NAPROXEN SODIUM
Active strength 220 mg/1
Pharmacologic classes Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A079096-001 NAPROXEN SODIUM NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 45 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 c2088c7a36db…2026-09-14 22:38:34 2026-08 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 84e616aacf4f…2026-08-18 06:07:40 2026-07 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A079096-001 NAPROXEN SODIUM EQ 200MG BASE TABLET / ORAL 2008-12-16 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A079096-001 NAPROXEN SODIUM EQ 200MG BASE TABLET / ORAL 2008-12-16 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A079096-001 NAPROXEN SODIUM 220MG TABLET / ORAL 2008-12-16 3bdfa0b2c4d7…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Socrata Ingredients# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 2 · 29 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Naproxen Sodium NAPROXEN SODIUM AAA Pharmaceutical, Inc. 5023ddcc-7931-e7b3-e063-6294a90a3b27 2026-10-28 Warnings Exact identifier application applno (ANDA): 079096 application number: ANDA079096 Naproxen Sodium NAPROXEN SODIUM HYVEE INC 45a0c910-7dd7-6a42-e063-6394a90a491c 2026-10-27 Warnings Exact identifier application applno (ANDA): 079096 application number: ANDA079096 NAPROXEN SODIUM NAPROXEN SODIUM AAA Pharmaceutical, Inc. 5ea3217d-845d-4781-b849-6b00babdc214 2026-10-20 Warnings Exact identifier application applno (ANDA): 079096 application number: ANDA079096 Medique Mediproxen NAPROXEN SODIUM Sportpharm LLC f01adfcc-b32a-4a98-a4e7-2ce87b824b5a 2026-04-24 Warnings Exact identifier application applno (ANDA): 079096 application number: ANDA079096 Naproxen Sodium NAPROXEN SODIUM HYVEE INC 45a00020-173b-a4a1-e063-6294a90ae399 2026-01-13 Warnings Exact identifier application applno (ANDA): 079096 application number: ANDA079096 Naproxen Sodium NAPROXEN SODIUM VALU MERCHANDISERS COMPANY 12748345-0d79-d6f8-e063-6394a90ab6c6 2025-12-11 Warnings Exact identifier application applno (ANDA): 079096 application number: ANDA079096 Naproxen Sodium NAPROXEN SODIUM VALU MERCHANDISERS COMPANY 1274889d-803c-d7fd-e063-6394a90ab9a8 2025-12-11 Warnings Exact identifier application applno (ANDA): 079096 application number: ANDA079096 Naproxen Sodium NAPROXEN SODIUM Chain Drug Marketing Association d9e72c3f-addc-4391-a7a4-2680a3e7f5c4 2025-12-10 Warnings Exact identifier application applno (ANDA): 079096 application number: ANDA079096 Naproxen Sodium NAPROXEN SODIUM Chain Drug Marketing Association 2ee83008-c012-48d6-9479-65e7d6f50f4c 2025-12-10 Warnings Exact identifier application applno (ANDA): 079096 application number: ANDA079096 CAREALL Naproxen NAPROXEN SODIUM New World Imports, Inc. d9a0c6e7-a70e-479a-9737-e81a2887c778 2025-12-01 Warnings Exact identifier application applno (ANDA): 079096 application number: ANDA079096 CAREALL Naproxen Sodium NAPROXEN SODIUM New World Imports, Inc. 3952324e-77f4-4117-a97a-ab5651130058 2025-12-01 Warnings Exact identifier application applno (ANDA): 079096 application number: ANDA079096 Medique at Home Mediproxen NAPROXEN SODIUM Unifirst First Aid Corporation b591ba4f-d7d3-4c81-e053-2995a90a7c6e 2025-09-09 Warnings Exact identifier application applno (ANDA): 079096 application number: ANDA079096 Medique Mediproxen NAPROXEN SODIUM Unifirst First Aid Corporation f6261d45-df1f-483b-b013-3cd6f78d9d43 2025-09-08 Warnings Exact identifier application applno (ANDA): 079096 application number: ANDA079096 Naproxen Sodium NAPROXEN SODIUM AMERIFOODS TRADING COMPANY f6dd2150-1643-18ff-e053-6294a90a422b 2025-07-15 Warnings Exact identifier application applno (ANDA): 079096 application number: ANDA079096 Naproxen Sodium NAPROXEN SODIUM Marc Glassman, Inc. 684e03b6-74eb-4374-a512-1c01ea216b51 2025-07-15 Warnings Exact identifier application applno (ANDA): 079096 application number: ANDA079096 Naproxen Sodium NAPROXEN SODIUM Marc Glassman, Inc. eeda0edf-7054-42aa-af8e-4df38b918f81 2025-07-15 Warnings Exact identifier application applno (ANDA): 079096 application number: ANDA079096 Naproxen Sodium NAPROXEN SODIUM CHAIN DRUG MARKETING ASSOCIATION, INC. 84b9e9a4-b805-420e-83be-ebe98776d1ee 2025-06-20 Warnings Exact identifier application applno (ANDA): 079096 application number: ANDA079096 Naproxen Sodium NAPROXEN SODIUM FSA STORE INC. f4326f99-142b-0b70-e053-2995a90ac951 2025-06-17 Warnings Exact identifier application applno (ANDA): 079096 application number: ANDA079096 Naproxen Sodium NAPROXEN SODIUM CHAIN DRUG MARKETING ASSOCIATION, INC. 04245a78-228e-439f-8ffb-9d9bc56c7bb7 2025-05-20 Warnings Exact identifier application applno (ANDA): 079096 application number: ANDA079096 NAPROXEN NAPROXEN SODIUM DISCOUNT DRUG MART c1dce2e4-ad7a-4462-a775-9a5bcb2375ed 2025-05-15 Warnings Exact identifier application applno (ANDA): 079096 application number: ANDA079096
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 27854-103-07 27854010307 40 PACKET in 1 BOX (27854-103-07) > 1 TABLET in 1 PACKET 40 packet 2019-11-04 2023-03-31 No No Current